Literature DB >> 10191433

The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.

A Swillen1, K Devriendt, E Legius, P Prinzie, A Vogels, P Ghesquière, J P Fryns.   

Abstract

In this contribution the current status and recent findings of the behavioural phenotype in VCFS (22q11 deletion) are discussed with regard to motor development, cognition and neurodevelopment, and behaviour and temperament. Motor: hypotonia in infancy, gross-motor milestones are delayed, problems with coordination and balance from preschool age on, problems with tempo/speed during adolescence. Cognition and neurodevelopment: learning disabilities (82-100%), intellectual disability (45%), better verbal abilities than performal abilities, poor attention and concentration, visuo-perceptual-spatia problems, good (auditory) memory. An important subgroup of children (55%) has a non-verbal learning disability (NLD). Behaviour and social-emotional development AD(H)D, withdrawn and shy, person-dependent social problems in relationships with peers, anxious, risk for child psychiatric problems as well as for the development of psychiatric problems during adolescence and early adulthood. Information on the behavioural phenotype in VCFS (22q11 deletion) is of great importance to clinicians as an aid to syndrome diagnosis, but even more to parents because it offers immense direct practical value to the management of the behaviour of their child. Appropriate counseling and information on the long-term expectations, and better insight in the behaviour will lead to the development of realistic ways of coping with their child.

Entities:  

Mesh:

Year:  1999        PMID: 10191433

Source DB:  PubMed          Journal:  Genet Couns        ISSN: 1015-8146


  56 in total

Review 1.  Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?

Authors:  E Stephen; A D Kindley
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

Review 2.  Cognitive characteristics of children with genetic syndromes.

Authors:  Tony J Simon
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2007-07

3.  Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study.

Authors:  Arun Kunwar; Seethalakshmi Ramanathan; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Anne Marie Higgins; Robert J Shprintzen; Wendy R Kates
Journal:  Schizophr Res       Date:  2012-02-22       Impact factor: 4.939

4.  Assessment of parental disclosure of a 22q11.2 deletion syndrome diagnosis and implications for clinicians.

Authors:  Dana Faux; Kelly Schoch; Sonja Eubanks; Stephen R Hooper; Vandana Shashi
Journal:  J Genet Couns       Date:  2012-08-31       Impact factor: 2.537

Review 5.  Clinical perspectives on the genetics of schizophrenia: a bottom-up orientation.

Authors:  Willem M A Verhoeven; Siegfried Tuinier
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 6.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

7.  The Severity of Vestibular Dysfunction in Deafness as a Determinant of Comorbid Hyperactivity or Anxiety.

Authors:  Michelle W Antoine; Sarath Vijayakumar; Nicholas McKeehan; Sherri M Jones; Jean M Hébert
Journal:  J Neurosci       Date:  2017-04-24       Impact factor: 6.167

Review 8.  Velocardiofacial syndrome: is there a neuropsychiatric phenotype?

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

Review 9.  A biologic model to study the genetics of psychotic, mood, and anxiety disorders: the velocardiofacial syndrome.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

10.  Regional cortical volumes and congenital heart disease: a MRI study in 22q11.2 deletion syndrome.

Authors:  Marie Schaer; Bronwyn Glaser; Marie-Christine Ottet; Maude Schneider; Meritxell Bach Cuadra; Martin Debbané; Jean-Philippe Thiran; Stephan Eliez
Journal:  J Neurodev Disord       Date:  2010-09-14       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.